Biotech

All Articles

Basilea ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's work establishing brand-new antifungals has actually obtained a significant...

Capricor sells Europe civil rights to late-stage DMD therapy for $35M

.Possessing presently gathered up the U.S. legal rights to Capricor Therapeutics' late-stage Duchenn...

FDA junks adcomm for Applied's uncommon condition drug

.After dismissing the decision meeting for Applied Therapeutics' metabolic condition medication govo...

Novo inks $600M NanoVation package to examine genetic medicines ex-liver

.Novo Nordisk is continuing its push in to genetic medicines, accepting compensate NanoVation Therap...

Innovent hyperlinks cytokine to intestines cancer actions

.Innovent Biologics has created the situation that its checkpoint inhibitor-cytokine blend healthy p...

Merck, Daiichi ADC attacks target in phase 3 bronchi cancer research

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows AI center along with collab to decide on cancer cells aim ats

.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has joi...

Ascendis' dwarfism medication favorites in period 3, intimidates BioMarin

.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, reporting stage 3 growth d...

Despite ph. 3 skip, Alkeus views road in advance for eye condition resource

.Though Alkeus Pharmaceuticals' dental eye health condition property neglected to dramatically minim...

Kairos goes public with $6M IPO to money tests of cancer medicine

.With a triad of biotechs reaching the Nasdaq on Friday, it was actually very easy to miss a smaller...